Revenue breakdown: Life Sciences (50.9%), Interventional (49.1%).
8-K
BD furnished recast historical financial information to reflect its Biosciences and Diagnostic Solutions business as discontinued operations following the February 9, 2026 spin-off and combination with Waters Corporation.